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Introduction {#sec1}
============

Recent decades have seen a marked rise in the number of novel and emerging human pathogenic viruses. This has resulted in a range of globally significant outbreaks and epidemics and a major loss of life. Examples include the SARS coronavirus (SARS-CoV-1) epidemic in 2003 with more than 8000 cases in 29 countries, the H1N1 influenza pandemic in 2009--2010 with 60 million cases in 214 countries, and the MERS coronavirus epidemic in 2012--2015 with approx. 2500 cases in 27 countries ([www.who.int](http://www.who.int/){#intref0010}). In December 2019, an outbreak related to a novel coronavirus (SARS-CoV-2) was reported in China which has been rapidly spreading globally with more than 6 million confirmed cases and more than 376,000 deaths by 2nd June, 2020 \[[@bib1]\].

Owing to the often high infectivity and rapid transmission of viruses, individual screening in clinical settings is often challenging. In addition, cases with mild or no symptoms are often overlooked, and hence epidemiological models and assessments of disease prevalence may be inaccurate. There is therefore a greater need to understand the spread of viral diseases at a community level which would provide information for the timely mitigation of outbreaks.

Municipal wastewater harbours a great variety of pathogenic viruses \[[@bib2]\]. Extensive research has been undertaken on the persistence of human enteric viruses (e.g. noroviruses, enteroviruses, adenoviruses, rotaviruses, hepatitis A/E viruses), transmitted via the faecal-oral route, in wastewater and in the aquatic environment \[[@bib3]\]. Enveloped viruses (e.g. coronaviruses), which rapidly inactivate without a host, have also been found in wastewater \[[@bib3]\]. Temporal changes in viral concentrations in wastewater can therefore indicate the presence or absence of a virus, related outbreaks in the population, and their effect on public health. Hence, domestic wastewater monitoring may be an important tool to assess and mitigate viral outbreaks in a community. In this review, we aim to critically assess the recent efforts on using wastewater surveillance to represent public health, with a focus on SARS-CoV-2 surveillance.

The current toolbox for wastewater viral monitoring {#sec2}
===================================================

Wastewater concentration for virus detection {#sec2.1}
--------------------------------------------

For the sensitive detection of viruses in wastewater, samples are often concentrated before quantification. Many different approaches are commonly used, as recently reviewed \[[@bib4],[@bib5]\]. For the surveillance of SARS-CoV-2, wastewater samples are often centrifuged or filtered to eliminate debris, followed by electronegative membrane filtration \[[@bib6]\], ultrafiltration \[[@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11]\] or polyethylene glycol precipitation \[[@bib8],[@bib9],[@bib12],[@bib13]\], aluminium flocculation \[[@bib14],[@bib15]\] or ultracentrifugation \[[@bib16],[@bib17]\] enabling 20x-800x concentration. Sludge samples were either subject to RNA extraction directly \[[@bib18]\], or viruses were eluted and PEG precipitated from the matrix \[[@bib11]\]. Most concentration methods are inexpensive and easy to set-up, however, they may be time-consuming and difficult to perform with high sample throughput, especially when high turbidity samples are processed. The main disadvantage of these methods is the co-concentration of organic compounds (e.g. humic substances), which often interfere with downstream virus detection or *in vitro* studies. Furthermore, concentration efficiency may vary among different samples, however, it has only been assessed in two studies aiming to detect SARS-CoV-2 in wastewater \[[@bib7],[@bib15]\], suggesting 3--50% viral recoveries ([Table 1](#tbl1){ref-type="table"} ). Therefore, appropriate process controls, for example, viruses of the same family or genus should be added to the sample to estimate viral recoveries \[[@bib15]\]. Alternatively, the concentration of a viral indicator, which is present in wastewater at high concentrations (e.g. gut-associated phages), can be compared between unprocessed and processed samples to assess concentration efficiency \[[@bib7]\].Table 1Methods used for wastewater concentration and SARS-CoV-2 RNA quantification. Gc: genome copies; MgV: mengovirus; PEDV: porcine epidemic diarrhoea virus; polyethylene glycol. ∗Preprint (not peer reviewed).Table 1RegionSampling datesWastewater typeVolume mlConcentrationRT-(q)PCR target regionProcess control recoverySARS-CoV-2 detection ratesSARS-CoV-2 concentration gc/100 mlReferenceMilan and Rome, Italy03/02/2020--02/04/2020Untreated wastewater250PEG/dextran precipitation of centrifuged supernatantORF1ab gene\
S geneNA12/12NA (PCR detection)\[[@bib33]\]Netherlands05/02/2020--16/03/2020Untreated wastewater36--150Centricon (Merck) ultrafiltration of centrifugated supernatantN gene\
E gene50% FRNA phage recoveryN1: 14/24\
N2: 0/24\
N3: 8/24\
E: 5/24NA\[[@bib7]\]∗Valencia, Spain12/02/2020--14/04/2020Untreated wastewater200Aluminium flocculation -- beef extract precipitationN geneNA12/1510^4^--10^5^\[[@bib14]\]∗Treated wastewater0/90Southeast Queensland, Australia24/02/2020--04/04/2020Untreated wastewater100--200pH adjustment to ∼4 and electronegative filtrationN geneNAN_Sarbecco: 1/9\
NIID_2019-nCOV_N: 0/912\[[@bib6]\]Centricon (Merck) ultrafiltration of centrifugated supernatantN_Sarbecco: 1/9\
NIID_2019-nCOV_N: 0/91.9Wuchang Fangcang Hospital, China26/02/2020--10/03/2020Untreated wastewaterNAPEG precipitation of centrifugated supernatantORF1\
N geneNA0/4\[[@bib13]\]∗Treated wastewater7/90.05--1.87 × 10^4^Paris, France05/03/2020--09/04/2020Untreated wastewater11UltracentrifugationE geneNA23/2310^3^--10^6^\[[@bib16]\]∗Treated wastewater6/810^2^--10^4^Paris, France05/03/2020--23/04/2020Untreated wastewater11UltracentrifugationE gene\
RdRp geneNA100%10^3^--10^6^\[[@bib17]\]∗Various locations, Israel10/03/2020--21/04/2020Untreated wastewater250--1000Primary: PEG or Alum precipitation of centrifuged supernatant.\
Secondary: Amicon ultrafiltrationE geneNA10/26NA\[[@bib8]\]∗Murcia, Spain12/03/2020--14/04/2020Untreated wastewater200Aluminium flocculation -- beef extract precipitationN genePEDV: 10.90 ± 3.54%\
MgV: 10.85 ± 2.11%N1: 21/42\
N2: 23/42\
N3: 27/42N1: 1.4 × 10^4^\
N2: 3.4 × 10^4^\
N3: 3.1 × 10^4^\[[@bib15]\]Treated wastewaterPEDV: 3.29 ± 1.58% MgV:6.19 ± 1.00%Secondary: 2/18\
Tertiary: 0/12\<2.5 × 10^4^Massachusetts, USA18/03/2020--25/03/2020Untreated wastewaterNAPEG precipitation of filtered sampleN geneNAN1: 4/6\
N2: 1/6\
N3: 4/6N1: 10^3^ -- 2 × 10^4^\
N2: 3 × 10^3^ -- 10^4^\
N3: 10^3^--10^4^\[[@bib12]\]∗New Haven, Connecticut, USA19/03/2020--01/05/2020Primary sludge2.5Direct RNA extractionN geneNA44/441.7 × 10^5^ -- 4.6 × 10^7^\[[@bib18]\]∗Bozeman, Montana, USA23/03/2020--08/04/2020Untreated wastewater500Corning Spin-X ultrafiltration of filtered sampleN geneNAN1: 7/7\
N2: 7/7N1: 10^2^--10^4^\
N2: 10^2^ -- 3 × 10^4^\[[@bib10]\]∗Ourense, Spain06/04/2020--21/04/2020Untreated wastewater250Amicon ultrafiltration of centrifugated supernatantN gene\
E gene\
RdRp geneMS2 phage: 33.3 ± 15.6%Influent: 5/5NA\[[@bib11]\]∗Treated wastewaterPrimary effluent: 1/4\
Effluent: 0/5SludgeGlycine/beef extract elution -- centrifugation -- filtration - PEG precipitation14/34Istambul, Turkey21/04/2020--25/04/2020Untreated wastewater250Amicon ultrafiltration OR PEG precipitation of centrifugated supernatantRdRp geneNA7/910^2^--10^5^\[[@bib9]\]∗

Amplification-based viral quantification {#sec2.2}
----------------------------------------

The most widely used methods for quantification of DNA and RNA viruses in wastewater are quantitative PCR (qPCR) and quantitative reverse transcription PCR (qRT-PCR), respectively \[[@bib4],[@bib19]\]. These methods detect a small segment of the viral genome, enabling rapid, sensitive and accurate strain-level detection of up to five targets in one assay \[[@bib20]\]. Several qRT-PCR assays have been designed for the detection of SARS-CoV-2 \[[@bib21], [@bib22], [@bib23], [@bib24]\], which are suitable for wastewater monitoring \[[@bib6],[@bib7],[@bib12],[@bib16]\]; however, the performance of the different assays may vary. Substantial differences in viral detection rates were observed when different primer/probes were used for quantification. For example, the 'N2' assay did not detect SARS-CoV-2 in wastewater samples which were positive for the 'N1' and 'N3' genes \[[@bib7]\]; hence the use of multiple primer/probe sets is recommended. A limitation of qPCR-based approaches is that the reverse transcription and polymerase enzymes are often inhibited by organic co-contaminants, which are concentrated and extracted together with the targets.

Recently, digital PCR--based approaches have also been used for viral detection in environmental samples \[[@bib19]\]. These methods enable the absolute quantification of the targets and are less sensitive to inhibition, however more expensive than qPCR-based assays. Other emerging technologies, including isothermal amplification and biosensors, are also suitable for viral RNA/DNA detection and quantification in environmental samples, providing results within an hour \[[@bib19]\]. Simple and affordable platforms (e.g. paper-based microfluidics devices) also have great potential for rapid, on-site viral detection in wastewater \[[@bib25]\], however, these assays are not as sensitive yet as traditional, PCR-based methods and have not been rigorously tested in the field \[[@bib26]\].

Culture-based analysis of viral infectivity {#sec2.3}
-------------------------------------------

Most human viruses are difficult to maintain *in vitro* and their culturing requires trained staff and specialized equipment. Hence, infectivity assays are rarely performed on wastewater samples. To date, the infectivity of SARS-CoV-2 in wastewater has not been assessed, even though culturable viral particles have been detected in the faeces and urine of infected individuals \[[@bib27],[@bib28]\]. These studies typically use Vero E6 cells to culture the SARS-CoV-2, and a similar approach may be suitable for the widespread screening of wastewater samples. Nonetheless, to investigate the temporal changes of viral infections in the community, molecular detection of viral genomes is sufficient.

Viromics and sequencing {#sec2.4}
-----------------------

Viral metagenomics of wastewater has been widely used to monitor the prevalence of multiple pathogens and could be used as an early warning system for the detection of outbreaks of novel viral pathogens \[[@bib29],[@bib30]\]. For example, a high-throughput sequencing approach was used as an alternative to q(RT-)PCR to explore the diversity of enterovirus D, hepatitis A and hepatitis E viruses \[[@bib31]\] and mastadenovirus \[[@bib32]\] in wastewater to assess the viral strains circulating in local populations of France and Australia, respectively. It may also be useful to monitor other respiratory viruses (e.g. influenza) alongside SARS-CoV-2, given the uncertainties about whether coinfection affects the outcome of COVID-19 cases. Untargeted sequencing applied during outbreaks can monitor genetic drift that might affect the detection efficacy of amplification primers used in both sequencing studies and in qPCR-based diagnostic tests. For example, complete genomes of norovirus have been recovered from wastewater containing mismatches in primer regions which would not amplify in qRT-PCR assays \[[@bib2]\]. So far, three studies performed sequencing of SARS-CoV-2 (q)PCR products derived from wastewater to verify the presence and potential origin of SARS-CoV-2 \[[@bib6],[@bib10],[@bib33]\]. Untargeted sequencing has not been used to investigate SARS-CoV-2 strains in wastewater.

Virus surveillance in wastewater {#sec3}
================================

Most studies on virus surveillance in wastewater have focused on the prevalence of human enteric viruses in wastewater and in wastewater-polluted environments. These studies have indicated good correlation between local viral outbreaks and high quantities of norovirus \[[@bib34]\], hepatitis A and E viruses \[[@bib35],[@bib36]\] and enterovirus D68 \[[@bib36],[@bib37]\] in sewage. Although the presence of respiratory viruses in wastewater has arguably received less attention, several countries have detected SARS-CoV-2 in sewage ([Table 1](#tbl1){ref-type="table"}). No SARS-CoV-2 was reported in wastewater before the first cases \[[@bib7]\]; however, there is some indication that SARS-CoV-2 was present in wastewater at Amersfoort, the Netherlands days before the first cases were reported \[[@bib38]\]. When the temporal changes in SARS-CoV-2 titres were assessed, viral concentrations showed good correlations with the number of COVID-19 cases in the community \[[@bib14],[@bib16],[@bib17]\]. Consequently, wastewater-based epidemiology may find future application as an early warning system for virus outbreaks, to monitor the progression of viral outbreaks, and in the provision of viral genomic data at the population scale.

Implications for the wider environment {#sec4}
======================================

Five studies have investigated viral titres in treated wastewater and three of those have found SARS-CoV-2 RNA in effluent with concentrations up to 10^4^ gc/100 ml, suggesting 1--2 log~10~ removal during wastewater treatment \[[@bib13],[@bib15],[@bib16]\]. Whether this poses a major risk to the wider environment remains unclear. However, recent reports suggest that SARS-CoV-2 can also infect and replicate in semiaquatic secondary animal vectors such as mink \[[@bib39],[@bib40]\]. This offers the potential for animals close to wastewater outlets to readily come into contact with SARS-CoV-2 from which it would likely become endemic in the secondary host. This is most likely to occur from the discharge of untreated sewage or from poorly treated wastewater close to watercourses (e.g. septic tanks). Considering the high concentrations of SARS-CoV-2 RNA in wastewater (up to 10^7^ genome copies/l) \[[@bib16]\], some virus particles may be intact and infectious in sewage and hence viral infectivity in treated and untreated wastewater should be investigated. However, even if sewage contains infectious viruses, the likelihood of humans contracting SARS-CoV-2 from bathing waters or shellfish is likely to be extremely low, given the low stability of the virus in water and the large dilution of wastewater in inland waterbodies or coastal regions.

Public health and policy {#sec5}
========================

Although the global clinical surveillance for COVID-19 has been established, there are a number of cases of asymptomatic individuals and those with very mild symptoms would not be identified and contacts not traced potentially missing an estimated 80% of actual transmission \[[@bib41]\]. Monitoring SARS-CoV-2 in wastewater is therefore ideally suited to describe the spatial and temporal trends in disease incidence. Wastewater-based epidemiology may be useful to identify emerging and re-emerging pathogens in a community and may serve as an early warning system, which would be useful for public health mitigation \[[@bib42],[@bib43]\]. However, translating the viral titres from wastewater into the actual number of cases within a community is highly challenging, if not impossible. This type of calculation relies on many assumptions, which still remain poorly quantified (e.g. the amount and dynamics of viral shedding in faeces, viral persistence in the sewer network, variation in wastewater flow due to climate, etc). In addition, while suited to large urban communities (i.e. populations \>10,000), the approach is less well suited from an economic and logistical perspective to disparate rural communities which may have hundreds of small water treatment facilities.

Although wastewater surveillance of SARS-CoV-2 provides a powerful tool to evaluate disease incidence at the community level, it is clear that they also need to be integrated into other public health initiatives \[e.g. campaign-based and randomised testing of individuals (i.e. presence of pathogen or antibodies), clinical case reporting, and mobile-based contact-tracking and self-reporting systems \[[@bib44]\]. This represents a significant challenge considering the poor integration of the environmental and clinical science communities. It may also require a harmonization of approaches (e.g. viral sequencing platforms and databases to match SARS-CoV-2 lineages detected in clinical and wastewater samples). It is also important to consider how best to ethically and legally balance public health with civil liberties when handling this information \[[@bib45]\]. One of the benefits of wastewater, however, is that it has limited sociological bias with few if any ethical issues.

Conclusions and recommendations {#sec6}
===============================

Current data on SARS-CoV-2 and other viruses suggest that wastewater-based epidemiology is a viable addition to the assessment and mitigation of viral outbreaks. Easy and straightforward methods are available for the concentration of wastewater samples for viral detection, however, the use of process controls (e.g. spiking the sample with an animal virus with structure similar to the target pathogen before concentration) is recommended. The widely used q(RT-)PCR approach enables rapid and strain level RNA/DNA quantification, however, the primers and probes should be chosen carefully. Although the infectivity state of the target virus is not relevant for epidemiological surveillance, the survival of SARS-CoV-2 in sewage, during wastewater treatment and in the aquatic environment should be investigated to assess health risks. Targeted and untargeted sequencing of wastewater viruses has the potential to track the spread of specific sequence variants and identify mutations that could affect detection in clinical settings.
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